Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
-5.19%
NET PROFIT MARGIN AVG 20Y
-10.31%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Dyne Therapeutics, Inc.
Market Cap
$2.89B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.82B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$2.72B
Net Profit Margin
-183.98%
TTM Avg
-2902.19%
3Y Avg
-1809.95%
5Y Avg
-1403.14%
Market Cap
$2.73B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.70B
Net Profit Margin
-33.44%
TTM Avg
-12.59%
3Y Avg
-3.87%
5Y Avg
-6.56%
Market Cap
$3.10B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.68B
Net Profit Margin
-0.91%
TTM Avg
-61.48%
3Y Avg
-31.69%
5Y Avg
-17.43%
Market Cap
$3.09B
Net Profit Margin
6.15%
TTM Avg
-37.77%
3Y Avg
-2241.27%
5Y Avg
-1494.18%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.89B | 0.00% | 0.00% | 0.00% | 0.00% |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 22.69% | 19.73% | -2.42% | -44.65% |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 1.85% | -5.88% | -8.36% | -6.41% |
| Precigen, Inc. (PGEN)vs › | $2.72B | -183.98% | -2902.19% | -1809.95% | -1403.14% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.73B | 0.00% | 0.00% | 0.00% | 0.00% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | -33.44% | -12.59% | -3.87% | -6.56% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| Neogen Corporation (NEOG)vs › | $2.68B | -0.91% | -61.48% | -31.69% | -17.43% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 6.15% | -37.77% | -2241.27% | -1494.18% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 10.56% | 9.25% | 0.54% | -8.48% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2017-12-31 | -300.21% |
| 2017-09-30 | -73.08% |
| 2017-06-30 | -163.54% |
| 2017-03-31 | 341.14% |
| 2016-12-31 | -23.01% |
| 2016-09-30 | -103.32% |
| 2016-06-30 | -483.73% |
| 2016-03-31 | -5.95% |
| 2015-12-31 | -61.75% |
| 2015-09-30 | -3.84% |
| 2015-06-30 | 23.92% |
| 2015-03-31 | -28.48% |
| 2014-12-31 | 6.96% |
| 2014-09-30 | -0.81% |
| 2014-06-30 | -23.42% |
| 2014-03-31 | -4.86% |
| 2013-12-31 | -3033.33% |
| 2013-09-30 | 4.93% |
| 2013-06-30 | -48.17% |
| 2013-03-31 | -44.65% |
| 2012-12-31 | 409.94% |
| 2012-09-30 | -8.62% |
| 2012-06-30 | -537.37% |
| 2012-03-31 | -32.77% |
| 2011-12-31 | -578.57% |
| 2011-09-30 | -14.53% |
| 2011-06-30 | -35.58% |
| 2011-03-31 | -15.25% |
| 2010-12-31 | -36.36% |
| 2010-09-30 | -3.10% |
| 2010-06-30 | -79.92% |
| 2010-03-31 | 16.90% |
| 2009-12-31 | -80.73% |
| 2009-09-30 | -35.40% |
| 2009-06-30 | -78.33% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | -0.88% |
| 2008-09-30 | 32.08% |
| 2008-06-30 | -289.36% |
| 2008-03-31 | -19.64% |
| 2007-12-31 | -6.35% |
| 2007-09-30 | 21.03% |
| 2007-06-30 | 10.00% |
